Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 1 10- and 15-year cause-specific survival rates for Connecticut and San Francisco-Oakland registries for 1981–1985 and 1991–1995 cohorts calculated by lognormal model (LN) and Kaplan-Meier (KM) method with 95% confidence intervals in brackets

From: Survival of patients with metastatic breast cancer: twenty-year data from two SEER registries

 

Connecticut

San Francisco-Oakland

Year

1981–1985

1991–1995

1981–1985

1991–1995

 

LN

KM

LN

KM

LN

KM

LN

KM

10

11.5 (6.2–16.8)

11.0 (8.5–13.5)

12.6 (7.3–17.9)

11.3 (7.8–14.8)

12.3 (7.0–17.6)

9.7(6.8–12.6)

17.0 (12.1–21.9)

15.9 (11.4–20.4)

15

7.1 (1.8–12.4)

8.3 (5.8–10.8)

9.1 (3.8–14.4)

N.A.

9.2 (3.9–14.5)

7.0 (4.3–9.7)

14.7 (9.8–19.6)

N.A.

  1. N.A. = not available
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us